Latest period
$278.00M
YoY change
+41.4%
5Y CAGR
-1.2%
Peak year (2021)
$2.23B
Latest annual
$1.89B
Operating Cash Flow history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: $1.89B
Operating Cash Flow growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: +41.4%
Operating Cash Flow history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | $1.89B | +41.4% | +$552.00M | ||
| 2024 | $1.33B | +4.9% | +$62.00M | ||
| 2023 | $1.27B | -26.0% | −$446.00M | ||
| 2022 | $1.72B | -23.1% | −$515.00M | ||
| 2021 | $2.23B | +11.4% | +$228.00M | ||
| 2020 | $2.00B | +61.3% | +$762.00M | ||
| 2019 | $1.24B | +3.6% | +$43.00M | ||
| 2018 | $1.20B | +2.1% | +$25.00M | ||
| 2017 | $1.18B | +9.9% | +$106.00M | ||
| 2016 | $1.07B | +32.0% | +$259.00M | ||
| 2015 | $810.00M | -13.6% | −$128.00M | ||
| 2014 | $938.00M | +43.9% | +$286.00M | ||
| 2013 | $652.00M | -45.1% | −$535.10M | ||
| 2012 | $1.19B | +32.6% | +$291.60M | ||
| 2011 | $895.50M | -19.9% | −$222.50M | ||
| 2010 | $1.12B | +12.1% | +$120.60M | ||
| 2009 | $997.40M | -6.2% | −$65.70M | ||
| 2008 | $1.06B | +14.7% | +$136.18M | ||
| 2007 | $926.92M | -2.6% | −$24.97M | ||
| 2006 | $951.90M | +11.8% | +$100.31M | ||
| 2005 | $851.58M | +6.6% | +$52.80M | ||
| 2004 | $798.78M | +20.5% | +$135.98M | ||
| 2003 | $662.80M | +11.1% | +$66.43M | ||
| 2002 | $596.37M | +28.0% | +$130.57M | ||
| 2001 | $465.80M | +26.1% | +$96.35M | ||
| 2000 | $369.45M | +48.1% | +$119.95M | ||
| 1999 | $249.50M | +76.4% | +$108.10M | ||
| 1998 | $141.40M | -19.8% | −$34.90M | ||
| 1997 | $176.30M | -299.2% | +$264.79M | ||
| 1996 | −$88.49M | — | — |
- 2025$1.89B+41.4%
- 2024$1.33B+4.9%
- 2023$1.27B-26.0%
- 2022$1.72B-23.1%
- 2021$2.23B+11.4%
- 2020$2.00B+61.3%
- 2019$1.24B+3.6%
- 2018$1.20B+2.1%
- 2017$1.18B+9.9%
- 2016$1.07B+32.0%
- 2015$810.00M-13.6%
- 2014$938.00M+43.9%
- 2013$652.00M-45.1%
- 2012$1.19B+32.6%
- 2011$895.50M-19.9%
- 2010$1.12B+12.1%
- 2009$997.40M-6.2%
- 2008$1.06B+14.7%
- 2007$926.92M-2.6%
- 2006$951.90M+11.8%
- 2005$851.58M+6.6%
- 2004$798.78M+20.5%
- 2003$662.80M+11.1%
- 2002$596.37M+28.0%
- 2001$465.80M+26.1%
- 2000$369.45M+48.1%
- 1999$249.50M+76.4%
- 1998$141.40M-19.8%
- 1997$176.30M-299.2%
- 1996−$88.49M—
Operating Cash Flow values are taken from Quest Diagnostics's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Cash Flow at Quest Diagnostics (DGX)
Operating Cash Flow for Quest Diagnostics (DGX): headline value $278.00M · YoY +41.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Quest Diagnostics (DGX) operating cash flow totalled $1.89B – surged 41.4% year-over-year.
Quest Diagnostics operating cash flow has grown for 2 consecutive years, with a -1.2% compound annual growth rate over 2020–2025 (5 years).
Quest Diagnostics operating cash flow peaked at $2.23B in 2021; the latest annual figure is $1.89B in 2025 (15.5% below peak).
2021 marks the peak operating cash flow at $2.23B, with the historical low of −$88.49M recorded in 1996.
Quest Diagnostics Operating Cash Flow by Year
Quest Diagnostics Operating Cash Flow 2025: $1.89B
2025's operating cash flow for Quest Diagnostics came in at $1.89B, surged 41.4% from 2024.
Quest Diagnostics Operating Cash Flow 2024: $1.33B
Quest Diagnostics posted operating cash flow of $1.33B in 2024, edged up 4.9% from 2023.
Quest Diagnostics Operating Cash Flow 2023: $1.27B
In 2023, Quest Diagnostics reported operating cash flow of $1.27B, declined 26.0% below 2022.
Quest Diagnostics Operating Cash Flow 2022: $1.72B
Quest Diagnostics operating cash flow in 2022 was $1.72B, declined 23.1% below 2021.
Quest Diagnostics Operating Cash Flow 2021: $2.23B
Quest Diagnostics operating cash flow in 2021 was $2.23B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Operating Cash Flow
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest operating cash flow
| $24.53B | |
| $19.70B | |
| $19.03B | |
| $18.56B | |
| $16.81B | |
| $16.47B | |
| $14.57B | |
| $9.96B |
- $24.53B
- $19.70B
- $19.03B
- $18.56B
- $16.81B
- $16.47B
- $14.57B
- $9.96B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation